Clinical Trial Update: Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus [NA]

View source ↗

Summary

A clinical trial evaluating empagliflozin versus linagliptin in kidney transplant recipients with diabetes to compare glycemic and renal outcomes and body compo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Linagliptin (linagliptin)

Snippet

Sponsor: Medanta, The Medicity, India | Conditions: Kidney Transplant; Complications, Diabetes Mellitus | NA | Status: RECRUITING